000 | 01780cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223030502.0 | ||
008 | 111012s2011 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aPh.D | ||
099 | _aCai01.19.03.Ph.D.2011.Yo.E | ||
100 | 0 | _aYomna Mohamed Mohamed Elmeligui | |
245 | 1 | 0 |
_aExpression of chemokine [MCP-1] and chemokine receptors [CXCR4, CCR2] in acute myeloid leukemia / _cYomna Mohamed Mohamed Elmeligui ; Supervised Magda Mahmoud Assem , Yasser Hassan Elnahass , Heba Nabil Raslan |
246 | 1 | 5 | _aإظهار الكيموكاين (إم سى بى-1) و مستقبلات الكيموكاين (سى إكس سى آر4 و سى سى آر2( فى سرطان الدم الميلودى الحاد |
260 |
_aCairo : _bYomna Mohamed Mohamed Elmeligui , _c2011 |
||
300 |
_a217 P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Clinical Pathology | ||
520 | _aIn this thesis we study AML blasts of different FAB subsets as to define their pattern of chemokine production and chemokine receptor expression by AML blasts depending on their degree of maturation this is done by determining the expression of chemokine receptors (CXCR4 and CCR2) and chemokine itself (MCP-1), which is the ligand of CCR2 | ||
530 | _aIssued also as CD | ||
653 | 4 | _aAcute myeloid leukemia | |
653 | 4 | _aCCR2 | |
653 | 4 | _aCXCR4 | |
700 | 0 |
_aHeba Nabil Raslan , _eSupervisor |
|
700 | 0 |
_aMagda Mahmoud Assem , _eSupervisor |
|
700 | 0 |
_aYasser Hassan Elnahass , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aEnas _eCataloger |
||
905 |
_aNazla _eRevisor |
||
942 |
_2ddc _cTH |
||
999 |
_c35713 _d35713 |